At1g07700 Antibody

What is the At1g07700 Antibody and what are its key specifications?

The At1g07700 Antibody (e.g., product code CSB-PA863204XA01DOA) is a polyclonal antibody raised in rabbits against recombinant Arabidopsis thaliana At1g07700 protein. It features the following specifications:

The antibody is specific to the At1g07700 target protein and has been validated for research applications .

What are the optimal storage conditions for maintaining At1g07700 Antibody activity?

For optimal preservation of At1g07700 Antibody activity:

• Upon receipt, store the antibody at -20°C or -80°C

• Avoid repeated freeze-thaw cycles to maintain integrity

• The antibody is provided in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative

• Working aliquots can be prepared to minimize freeze-thaw cycles

• Prior to use, thaw completely but gently to prevent denaturation

Working with small aliquots rather than repeatedly freezing and thawing the entire stock is critical for maintaining antibody performance across experiments.

How should researchers optimize Western blotting protocols when using At1g07700 Antibody?

Optimization of Western blotting for At1g07700 detection requires attention to several parameters:

Performing a dilution series experiment can help identify the optimal antibody concentration that balances specific signal with minimal background. Signal verification using competing peptide blocking controls can confirm specificity .

What are the critical validation steps required when first working with At1g07700 Antibody?

When introducing At1g07700 Antibody into your research workflow, validation is essential:

• Specificity validation: Test the antibody on samples with known At1g07700 expression levels, ideally including knockout/knockdown controls

• Size verification: Confirm that detected bands match the expected molecular weight of At1g07700 protein

• Reproducibility assessment: Perform technical replicates to ensure consistent results

• Cross-reactivity testing: If working with multiple plant species, verify specificity across species

• Application-specific validation: For each new application (ELISA, immunohistochemistry, etc.), perform separate validation studies

These validation steps establish confidence in experimental results and help troubleshoot potential issues before they affect research outcomes.

What are common causes of weak or absent signals when using At1g07700 Antibody, and how can they be addressed?

When experiencing detection issues with At1g07700 Antibody, consider these potential causes and solutions:

Systematic troubleshooting by changing one parameter at a time helps identify the specific issue affecting antibody performance .

How can competitive binding phenomena affect At1g07700 Antibody experiments and how should researchers account for these effects?

Competitive binding can significantly impact experimental outcomes with antibodies. Based on competitive antibody binding models:

• Binding site competition: When multiple antibodies target overlapping epitopes, they compete for binding sites, potentially reducing signal

• Concentration effects: Antibody binding is concentration-dependent; higher concentrations may not proportionally increase signal due to saturation effects

• Statistical binding probabilities: Each binding site has a certain statistical weight that depends on both binding site characteristics and antibody properties (affinity, concentration)

To account for these effects, researchers should:

• Perform titration experiments to establish optimal antibody concentrations

• Consider using computational models to predict binding under competitive conditions

• Interpret quantitative results within the context of potential binding competition

• When combining multiple antibodies, verify they don't interfere with each other's binding

How can researchers apply biophysical models to predict At1g07700 Antibody binding in complex experimental systems?

Advanced research with At1g07700 Antibody may benefit from predictive binding models:

• Transfer matrix method: This computational approach calculates the probability of antibody binding at specific sites by considering:

  • Number of binding sites on the target protein

  • Number of sites an antibody covers when bound

  • Site-specific binding affinities

  • Antibody concentration

• Parameter determination: Experimental binding curves can be used to extract affinity values for model parameterization

• Competitive binding predictions: Once parameterized, models can predict how antibody binding changes under different conditions

• Applications:

  • Predicting effects of adding monoclonal or pooled antibodies to complex samples

  • Optimizing experimental conditions to maximize specific binding

  • Understanding mechanistic aspects of antibody-target interactions

Such models are especially valuable when working with complex samples containing potential binding competitors .

What considerations are important when integrating At1g07700 Antibody into multi-omics experimental workflows?

When incorporating At1g07700 Antibody into multi-omics studies:

• Correlation with transcriptomics:

  • Compare protein levels (via antibody detection) with mRNA expression data

  • Discrepancies may indicate post-transcriptional regulation

  • Consider time-course experiments to capture expression dynamics

• Proteomics integration:

  • Use immunoprecipitation followed by mass spectrometry to identify interaction partners

  • Compare antibody-based quantification with label-free proteomics data

  • Validate key findings using orthogonal methods

• Functional genomics connections:

  • Combine antibody-based expression analysis with phenotypic data from knockout/knockdown studies

  • Correlate protein expression with metabolomic changes

• Data normalization and integration:

  • Develop robust normalization strategies across different data types

  • Apply appropriate statistical methods for integrated analysis

  • Consider biological and technical variation in each data type

This integrated approach provides more comprehensive understanding of At1g07700 function within biological systems .

How can researchers assess potential neutralizing activity against At1g07700 in immunological studies?

When investigating potential neutralizing activity:

• Functional assays: Develop assays that measure At1g07700 functional activity in the presence/absence of antibody

• Epitope mapping: Identify which regions of At1g07700 are recognized by the antibody and determine if these regions are functionally important

• Neutralization assessment: Similar to approaches used for therapeutic antibodies, researchers can:

  • Compare antibody binding to functional inhibition

  • Assess dose-dependent neutralization effects

  • Determine if neutralization correlates with specific epitopes

• Memory response evaluation: For in vivo studies, assess whether exposure leads to development of protein-specific memory B cells

These approaches parallel methods used to characterize therapeutic antibody neutralization, as documented in studies of other antibody targets .

What methodological considerations are important when using At1g07700 Antibody for investigating protein-protein interactions?

For protein interaction studies using At1g07700 Antibody:

• Immunoprecipitation optimization:

  • Determine optimal antibody-to-sample ratio

  • Test different lysis/binding buffers to preserve interactions

  • Include appropriate controls (IgG control, input sample)

• Cross-linking considerations:

  • For transient interactions, consider chemical cross-linking before immunoprecipitation

  • Optimize cross-linker concentration and reaction time

  • Account for potential epitope masking by cross-linkers

• Co-localization studies:

  • Combine At1g07700 Antibody with antibodies against suspected interaction partners

  • Optimize fixation methods to preserve protein localization

  • Use super-resolution microscopy for detailed co-localization analysis

• Validation approaches:

  • Confirm interactions using reciprocal immunoprecipitation

  • Validate key interactions with orthogonal methods (e.g., proximity ligation assay)

  • Consider functional assays to assess biological relevance of interactions

These methodologies enable robust characterization of At1g07700 protein interaction networks and functional relationships .